Evidence map›Paper›PMID 39060690›Full record

ArticleAnnals of surgical oncology2024

Circulating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence.

Beatrice J Sun, Amy Y Li, Dong G Hur, Maggie Zhou, George A Poultsides, Daniel J Delitto, Byrne Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Minimal Residual Disease in Metastatic Soft Tissue Sarcoma.Current treatment options in oncology · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Beatrice J SunSection of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. sunbj@stanford.edu.ORCID http://orcid.org/0000-0002-5053-6730
Amy Y LiDivision of Surgical Oncology, Department of Surgery, University of California, Irvine School of Medicine, Orange, CA, USA.
Dong G HurSection of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Maggie ZhouDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
George A PoultsidesSection of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Daniel J DelittoSection of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Byrne LeeSection of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Circulating Tumor DNANeoplasm Recurrence, LocalSarcomaBiomarkers, TumorHumansPrognosisBiomarkers, TumorCirculating Tumor DNA

Identifiers

PMID39060690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.